172 related articles for article (PubMed ID: 37179284)
1. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
[TBL] [Abstract][Full Text] [Related]
3. PKNOX2 expression and regulation in the bone marrow mesenchymal stem cells of Fanconi anemia patients and healthy donors.
Cagnan I; Cosgun E; Konu O; Uckan D; Gunel-Ozcan A
Mol Biol Rep; 2019 Feb; 46(1):669-678. PubMed ID: 30515693
[TBL] [Abstract][Full Text] [Related]
4. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients.
Cagnan I; Keles M; Keskus AG; Tombaz M; Sahan OB; Aerts-Kaya F; Uckan-Cetinkaya D; Konu O; Gunel-Ozcan A
Hum Cell; 2022 Jan; 35(1):111-124. PubMed ID: 34792755
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.
Mantelli M; Avanzini MA; Rosti V; Ingo DM; Conforti A; Novara F; Arrigo G; Boni M; Zappatore R; Lenta E; Moretta A; Acquafredda G; de Silvestri A; Cirillo V; Cicchetti E; Algeri M; Strocchio L; Vinti L; Starc N; Biagini S; Sirleto P; Bernasconi P; Zuffardi O; Maserati E; Maccario R; Zecca M; Locatelli F; Bernardo ME
Br J Haematol; 2015 Sep; 170(6):826-36. PubMed ID: 26010568
[TBL] [Abstract][Full Text] [Related]
6. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
[TBL] [Abstract][Full Text] [Related]
7. Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells.
Xu J; Li X; Cole A; Sherman Z; Du W
Stem Cells; 2018 May; 36(5):785-795. PubMed ID: 29377497
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.
Haga CL; Boregowda SV; Booker CN; Krishnappa V; Strivelli J; Cappelli E; Phinney DG
Cytotherapy; 2023 Apr; 25(4):362-368. PubMed ID: 36481320
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.
Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J
Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808
[TBL] [Abstract][Full Text] [Related]
11. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
14. Changes in vimentin, lamin A/C and mitofilin induce aberrant cell organization in fibroblasts from Fanconi anemia complementation group A (FA-A) patients.
Capanni C; Bruschi M; Columbaro M; Cuccarolo P; Ravera S; Dufour C; Candiano G; Petretto A; Degan P; Cappelli E
Biochimie; 2013 Oct; 95(10):1838-47. PubMed ID: 23831462
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
16. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
17. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anemia and the development of leukemia.
Alter BP
Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
